Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.92+0.45 (+3.92%)
At close: 04:00PM EST
11.92 -0.00 (-0.01%)
After hours: 04:01PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts4234
Avg. Estimate-0.44-0.28-1.15-0.97
Low estimate-0.77-0.77-1.5-2.97
High estimate-0.250.2-0.950.79
Year ago EPS0.120.011.62-1.15
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts6377
Avg. Estimate82.61M78.94M338.92M341.24M
Low estimate76.82M75M330M314.36M
High estimate87.65M83.43M358M384.39M
Year ago sales110.42MN/A475.82M338.92M
Sales growth (year/est)-25.20%N/A-28.80%0.70%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS0.230.07-0.15-0.22
Actual EPS0.120.01-0.36-0.34
Difference-0.11-0.06-0.21-0.12
Surprise %-47.80%-85.70%-140.00%-54.50%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.44-0.28-1.15-0.97
7 days ago-0.44-0.28-1.15-0.92
30 days ago-0.44-0.28-1.15-0.92
60 days ago-0.44-0.28-1.15-0.92
90 days ago-0.240.22-1.24-0.31
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A11
Growth estimatesCHRSIndustrySector(s)S&P 500
Current qtr.-466.70%N/AN/AN/A
Next qtr.-2,900.00%N/AN/AN/A
Current year-171.00%N/AN/AN/A
Next year15.70%N/AN/AN/A
Next 5 years (per annum)-25.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A